Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Pfizer
3815
Pfizer
Breakthroughs that change patients' lives
Suggest edits
Type
B2b
Follow us
Also headquartered in New York
Verizon
IBM
HBO
Bloomberg
Goldman Sachs
JPMorgan
Kickstarter
Wired
Morgan Stanley
The New York Times
Alexa global traffic share
Twitter followers
Overview
Investments
34
Add info
Team Size
1–10
Employees
I work here
Location
New York
,
United States
Headquarters
Explore New York
Ars Technica
Older adults got higher omicron protection by switching from Pfizer to Moderna
SiliconRepublic
Pfizer snaps up migraine drugmaker Biohaven for $11.6bn
Pulse 2.0
,
MedCity News
Why Pfizer (PFE) Is Buying Biohaven Pharmaceutical (BHVN) For $11.6 Billion In Cash
Business Plus
Pfizer profits breeze past Wall Street expectations
MedCity News
FDA lifts Pfizer gene therapy clinical hold, but trial adds new safety measures
MedCity News
Biohaven migraine drug partnered with Pfizer lands twin European approvals
CNET
Pfizer Recalls Some Batches of Its Blood Pressure Medication
SiliconBeat
Covid-19 booster raises antibody levels against Omicron for children ages 5 through 11, Pfizer and BioNTech say
Pulse 2.0
Pfizer (PFE) Stock: $75 Price Target And Overweight Rating
Pulse 2.0
Pfizer (PFE) Stock: $55 Price Target And Equal-Weight Rating
Pulse 2.0
Pfizer (PFE) Stock: $57 Price Target From Citi
Pulse 2.0
,
MedCity News
Why Pfizer (PFE) Is Buying ReViral For Up To $525 Million
Pulse 2.0
Pfizer (PFE) Stock: Why The Price Increased Today
Ars Technica
Pfizer, Moderna vaccines spur slightly different antibodies, study finds
MedCity News
Data and regulatory roundup: Pfizer’s feat, an ADHD miss, Eli Lilly’s CRL & more
MedCity News
AN2 Therapeutics’ IPO raises $69M to take antibiotic from Pfizer into pivotal test
MedCity News
Pfizer CEO pushes annual Covid shot, but experts disagree
MedCity News
Alnylam sues Moderna & Pfizer, claiming Covid-19 vaccines infringe lipid patent
CNET
Pfizer Asks FDA to Authorize Extra COVID Booster for Older Adults
Tech Times
Pfizer Pushes for 4th COVID-19 Vaccine Dose: Is This for Life After the Pandemic?